Exicure, Inc. (XCUR)
Last updated: 2026-10-22 07:56:20. Prices reflect the latest closing data and will resume updating on the next trading day. Stock price data is sourced from Massive.
Summary
Exicure, Inc. (XCUR) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NASDAQ. The stock is currently priced at $1.03, with a market capitalization of $6.54M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $0.94 to $9.48. This page covers its latest market performance, valuation, price trends and company information.
Key Market Data
$6.54M | |
$0.98 | |
$576.00 | |
$0.94 | |
$1.00 | |
40.28K | |
39.79K | |
-- | |
$9.48 | |
$0.94 | |
-- | |
-- |
Exicure, Inc. (XCUR) Latest Closing Stock Price
Exicure, Inc. (XCUR) last closed at $1.00 as of 2026-10-21 23:53:00, unchanged from the previous close of $1.00.
During the latest regular trading session, XCUR traded between $0.94 and $576.00, with a volume of 40.28K shares. The closing price was near the lower end and near the lower end of its 52-week range.
Exicure, Inc. (XCUR) 7-Day Stock Price Change
Over the past seven days, Exicure, Inc. (XCUR) moved from $1.15 to $1.03, representing a decline of 10.26% ($0.12).
The stock traded between $0.97 and $1.30 during the period. The latest price is near the lower end of the 7-day range, indicating strong downward.
The average daily volume was 39.27 thousand shares, down versus the previous seven-day period, indicating lower trading activity.
XCUR 52-Week Price Position
Position in Range: 1.1%
XCUR is currently trading at $1.03, placing it 1.1% of the way from its 52-week low of $0.94 to its 52-week high of $9.48. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
What is Exicure, Inc. (XCUR)?
Exicure Inc is a clinical-stage biotechnology company focused on developing treatments for blood-related diseases, with an emphasis on small-molecule therapies that have the potential to benefit a broad range of patients. The company acquired GPCR Therapeutics USA and secured a license for GPC-100 (Burixafor), a clinical-stage small-molecule compound that inhibits the chemokine receptor CXCR4. GPC-100 has demonstrated the ability to effectively mobilize various cell types, including hematopoietic stem cells and lymphocytes, highlighting its broad therapeutic potential across multiple indications.
Exicure, Inc. Information
| Industry | PHARMACEUTICAL PREPARATIONS |
| Employees | 8 |
| Exchange | NASDAQ |
| Company Website |
How to Buy Exicure, Inc. (XCUR) Stock on MEXC
Eligible investors can buy real shares of Exicure, Inc. (XCUR) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.
Frequently Asked Questions (FAQ)
1.What is Exicure, Inc. (XCUR) stock price today?
2.Is XCUR stock going up or down today?
3.What is XCUR pre-market price?
4.What is XCUR after-hours price?
5.Is XCUR stock trading now?
6.Where does XCUR sit relative to its 52-week high and low?
7.What sector is Exicure, Inc. in?
8.What is Exicure, Inc.'s market capitalization and where is it listed?
9.How is XCUR valued in terms of P/E ratio and EPS?
10.Does Exicure, Inc. pay a dividend?
Explore More US Stocks
Search Stocks
XCUR Stock Calculator
Estimate the value between XCUR shares and USD.
XCUR Shares to USD
1.00 XCUR shares = 1.032 USD
Calculations are estimates based on the latest available price and are for reference only.


